Hilary Daniel, BS; Sue S. Bornstein, MD; for the Health Public Policy Committee of the American College of Physicians *
Financial Support: Financial support for the development of this position paper came exclusively from the ACP operating budget.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-0013.
Corresponding Author: Hilary Daniel, BS, American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001; e-mail, email@example.com.
Current Author Addresses: Ms. Daniel: American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001.
Dr. Bornstein: 3111 Beverly Drive, Dallas, TX 75205.
Author Contributions: Conception and design: H. Daniel, S.S. Bornstein, F. Syed, J. Quinton.
Analysis and interpretation of the data: H. Daniel, J.K. Carney, T.G. Cooney, T.L. Henry.
Drafting of the article: H. Daniel, F. Syed.
Critical revision of the article for important intellectual content: H. Daniel, S.S. Bornstein, J.K. Carney, T.G. Cooney, L.S. Engel, H.E. Gantzer, T.L. Henry, M.B. Southworth, F. Syed, J. Quinton, M.A. Wallace.
Final approval of the article: H. Daniel, S.S. Bornstein, J.K. Carney, T.G. Cooney, L.S. Engel, H.E. Gantzer, T.L. Henry, J.D. Lenchus, B.M. McCandless, M.B. Southworth, F. Syed, J. Quinton, M.A. Wallace, A. Valdrighi.
Administrative, technical, or logistic support: H. Daniel.
Collection and assembly of data: H. Daniel.
The increasing price of prescription drugs is an ongoing concern for Medicare and Medicaid, particularly for patients with chronic health conditions who are using multiple medications and patients in these programs taking high-priced brand-name specialty drugs. Shifts in benefit design, including higher deductibles and a movement away from copayments to coinsurance, have increased patient out-of-pocket costs and put pressure on program budgets. In this paper, the American College of Physicians expands on its position paper from 2016 and offers additional recommendations to decrease out-of-pocket costs for patients, enhance the government's purchasing power, and address existing policies that add costs to the health care system.
Daniel H, Bornstein SS, for the Health Public Policy Committee of the American College of Physicians. Policy Recommendations for Public Health Plans to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians. Ann Intern Med. 2019;171:825–827. [Epub ahead of print 12 November 2019]. doi: https://doi.org/10.7326/M19-0013
Download citation file:
Published: Ann Intern Med. 2019;171(11):825-827.
Published at www.annals.org on 12 November 2019
Healthcare Delivery and Policy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use